Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APRI 28 0.15 MG

DESOGESTREL : 0.15 MG ETHINYL ESTRADIOL : 0.03 MG · DIN 02317206 · TEVA CANADA LIMITED

Health Canada status: MARKETED

What is APRI 28?

APRI 28 0.15 MG contains DESOGESTREL : 0.15 MG ETHINYL ESTRADIOL : 0.03 MG. It is listed in the Health Canada Drug Product Database under DIN 02317206, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 28-May-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is APRI 28 used for?

APRI ® (desogestrel / ethinyl estradiol tablets, USP) is indicated for: • Conception control

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02317206
Brand nameAPRI 28
Generic / active ingredientDESOGESTREL : 0.15 MG ETHINYL ESTRADIOL : 0.03 MG
ManufacturerTEVA CANADA LIMITED
Strength0.15 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeG03AA09 DESOGESTREL AND ESTROGEN
AHFS class68:12.00
BiosimilarNo
Health Canada statusMARKETED
Status date28-May-2015
Original market date2008-09-29 00:00:00

How is it stored and handled?

null

How is it supplied?

APRI ® 21: Each sachet contains an Aclar blister dispenser with 21 round rose active tablets. APRI ® 28: Each sachet contains an Aclar blister dispenser with 21 round rose active tablets and 7 round white inert tablets.

What can be used instead?

Other Canadian products sharing ATC code G03AA09 DESOGESTREL AND ESTROGEN. 10 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APRI 210.03 MGTABLETTEVA CANADA LIMITEDMARKETEDDIN 02317192
FREYA 210.15 MGTABLETMYLAN PHARMACEUTICALS ULCMARKETEDDIN 02396491
FREYA 280.03 MGTABLETMYLAN PHARMACEUTICALS ULCMARKETEDDIN 02396610
MARVELON 210.03 MGTABLETORGANON CANADA INC.MARKETEDDIN 02042487
MARVELON 280.15 MGTABLETORGANON CANADA INC.MARKETEDDIN 02042479
MILEY 210.15 MGTABLETAMBICARE PHARMACEUTICALS INC.MARKETEDDIN 02556553
MILEY 280.15 MGTABLETAMBICARE PHARMACEUTICALS INC.MARKETEDDIN 02556561
MIRVALA 210.1500 MGTABLETAPOTEX INCMARKETEDDIN 02410249
MIRVALA 280.0300 MGTABLETAPOTEX INCMARKETEDDIN 02410257
MARFEM 210.03 MGTABLETNOVOPHARM LIMITEDCANCELLED PRE MARKETDIN 02328828

Who else supplies DESOGESTREL AND ESTROGEN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. DESOGESTREL AND ESTROGEN appears in 87 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for APRI 28

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for APRI 28

Health Canada Drug Product Database (DPD), DIN 02317206. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.